Riskpilot← Back to searchSign inGet full accessBSN Medical AB
ABDissolvedOrg 5566056197Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20010 employees
Revenue 2021
SEK -31K
-104% vs 2020
EBITDA margin
167.7%
-112% vs 2020
Equity ratio
4.9%
Financial strength
Net profit 2021
SEK -3,4M
-26% vs 2020
| Revenue | SEK -31K | -104% |
| EBITDA | SEK -52K | -112% |
| Net profit | SEK -3,4M | -26% |
| Total assets | SEK 643,5M | +2% |
| Equity | SEK 31,8M | -8% |
| Employees | 0 | — |
Legal name
BSN Medical AB
Org number
5566056197
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
19 februari 2001
Share capital
SEK 113 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall idka handel med sjukvårdsprodukter.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 256 480 | 280 746 | 240 872 | 803 | −31 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 53 077 | 61 201 | 406 642 | 421 | −52 |
| Depreciation & amort. | −98 | −144 | −178 | −50 | −10 |
| EBIT | 52 979 | 61 057 | 406 464 | 371 | −62 |
| Net financials | 2 245 | −164 | −1 264 | −2 980 | −3 987 |
| Profit before tax | −394 | −72 | 2 632 | −2 599 | −4 049 |
| Tax | −0 | −0 | −595 | −130 | 605 |
| Net profit | −394 | −72 | 2 037 | −2 729 | −3 444 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 82 462 | 46 126 | 40 763 | 633 957 | 643 483 |
| Equity | 34 680 | 36 056 | 38 768 | 34 498 | 31 796 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 47 713 | 10 080 | 2 006 | 599 459 | 611 687 |
| Total debt | 47 713 | 10 080 | 2 006 | 599 459 | 611 687 |
EBITDA margin
-5200000.0%
This company
15.8%
Market median
-32911492% vs market
20172021
Equity ratio
4.9%
This company
38.2%
Market median
-87% vs market
20172021
Return on equity
-10.8%
This company
18.4%
Market median
-159% vs market
20172021
Net profit margin
-344400000.0%
This company
8.1%
Market median
-4251851952% vs market
20172021
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20172021
Debt / equity
19.24×
This company
0.62×
Market median
-3003% vs market
20172021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MT Chief Auditor | Chief Auditor | 2021 |
| Former (1) | ||
AG Chief Auditor | Chief Auditor | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2020 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Former (1) | ||
| Chairman | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BSN Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Andreas Gunnar Mast | Chief Auditor | 0 companies |
| Mikael Thomas Gunnar Edman | Chief Auditor | 0 companies |
| Jens Frederik Nielsen | Chairman | 0 companies |
| Karin Eva Gabriele von Uthmann | Board of Directors | 0 companies |
| David Hall | Board of Directors | 0 companies |
| Ingrid Agneta Sannum | Chairman | 0 companies |